Blog
Featured post
Expanded clinical notes and medical images available to advance research
Today we are excited to announce the availability of expanded concepts from clinical notes -- including family history, medication details reported to providers, and complex...
Expanding customer options to achieve research success
Truveta Data delivers complete EHR data, including clinician notes and images, from more than 30 health systems, linked with SDOH, mortality and claims data, for scientifically...
Truveta wins 2024 Stevie Awards for Most Innovative Company and Achievement in Technology
Truveta was named winner of a Gold Stevie® Award for Achievement in Science or Technology, as well as a Silver for Most Innovative Company of the Year in the 22nd Annual American...
Advancing maternal and pediatric research with the largest and most complete mother and child EHR dataset
Today, we are excited to announce the largest and most complete mother-child electronic health record (EHR) dataset for scientifically rigorous research on mothers and their...
Our journey of applying generative AI to advance healthcare
Truveta recently won the SXSW Innovation Award for Artificial Intelligence, which recognized the groundbreaking work we have been doing to apply modern generative AI technology...
Ending the HIV epidemic: Finding new insights with EHR data
In 2019, the US government unveiled the ambitious Ending the HIV Epidemic (EHE) plan, aiming to slash new HIV infections by 90% by 2030. Thanks to advances in antiretroviral...
Real-time monitoring of respiratory virus-associated hospitalizations: Trends from October 2019 through March 2024
Overall, the rate of hospitalizations associated with respiratory viruses has decreased throughout March 2024 (-32.4%) compared to February 2024. For infants and children, we see...
Trends in the incidence of syphilis among US adults since 2019
Truveta Research explored the monthly trends in the incidence of syphilis among US adults from January 2019 to December 2023. During the early months of the COVID-19 pandemic,...
Device label expansion using real-world data
US spending on medical devices and in-vitro diagnostics totals more than $199 billion a year, with most of the costs associated with clinical development. Label expansion...